THE US Food and Drug
Administration has approved a
new allergy medicine, Allegra, for
over-the-counter use.
Manufactured by Sanofi-Aventis,
Allegra has been approved for the
treatment of persons aged over
two years, and will be available in
its prescription strength without a
prescription in US pharmacies
from March this year.
MEANWHILE the FDA has also
announced a possible association
between saline and silicone gelfilled
breast implants and
anaplastic large cell lymphoma.
The warning comes on the heels
of data collected by the FDA which
suggests that patients with breast
implants “may have a very small
but significant risk of ALCL in the
scar capsule adjacent to the implant.”The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jan 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jan 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.